XBIT
What one share of XBiotech holds
Pharmaceutical Preparations
XBiotech Inc. (“XBiotech” or the “Company”) is a biopharmaceutical company that discovers and develops True Human™ monoclonal antibodies for treating a variety of diseases. XBiotech was incorporated in Canada on March 22, 2005.
XBiotech’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$1.48 |
|---|---|
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$1.34 |
| Cash and investments | $3.59 |
| Book value | $4.21 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | — | −$1.63 | $0.15 | −$1.57 | — | $1.81 |
| 2017 | — | −$0.95 | $0.04 | −$1.01 | — | $1.70 |
| 2018 | $0.00 | −$0.59 | $0.00 | −$0.47 | — | $1.15 |
| 2019 | $0.00 | $14.44 | $0.00 | −$0.40 | — | $18.20 |
| 2020 | $1.43 | −$0.36 | $0.12 | −$2.23 | — | $11.90 |
| 2021 | $0.61 | −$0.58 | $0.12 | $2.19 | — | $8.85 |
| 2022 | $0.13 | −$1.08 | $0.02 | −$0.51 | — | $7.90 |
| 2023 | $0.00 | −$0.81 | $0.01 | −$0.63 | — | $7.19 |
| 2024 | — | −$1.26 | $0.04 | −$1.06 | — | $5.98 |
| 2025 | — | −$1.49 | $0.01 | −$1.32 | — | $4.60 |